Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study
2014 ◽
Vol 16
(12)
◽
pp. 833-839
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21633-e21633
2014 ◽
Vol 18
(2)
◽
pp. 126-136
◽
2019 ◽
Vol 36
(1)
◽
pp. 63-72
◽
2009 ◽
Vol 38
(3)
◽
pp. 398-405
◽
Keyword(s):
2016 ◽
Vol 75
(5)
◽
pp. 957-966.e2
◽